| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 04/25/2002 | WO2001097810A3 Use of therapeutic benzamide derivatives |
| 04/25/2002 | WO2001085683A3 Pyrrolyl-, furanyl- and thienyl-substituted p-aminophenols and colorants containing said compounds |
| 04/25/2002 | WO2001058891A3 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage |
| 04/25/2002 | US20020049344 New vitamin d derivatives with carbo-or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments |
| 04/25/2002 | US20020049338 Process for the preparation of 2-aryl-5- (perfluoro-alkyl) pyrrole compounds from N-[1-chloro-1-(perfluoroalkyl) methyl] arylimidoyl chloride compounds |
| 04/25/2002 | US20020049248 Alone or in combination for treatment of adult-T-cell leukemia- lymphoma |
| 04/25/2002 | US20020049243 Pyrrolidine derivatives |
| 04/25/2002 | US20020049231 S(-)-3-aminothalidomide; treating wide variety of diseases including diabetic retinopathy |
| 04/25/2002 | US20020049199 N-linked carbamates and ureas of heterocyclic thioesters |
| 04/25/2002 | US20020049193 Inhibitors of the enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase, or rotamase, enzyme activity. |
| 04/25/2002 | US20020049165 Inhibiting the enzymatic activity of HIV protease |
| 04/25/2002 | US20020049135 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
| 04/25/2002 | US20020048687 Efficient light emission and excellent heat resistance |
| 04/25/2002 | DE10050492A1 New butenolide or pentenolide amide derivatives, useful as kinase inhibitors for treating inflammatory and autoimmune diseases, e.g. rheumatoid arthritis, asthma, Alzheimer's disease or osteoarthritis |
| 04/25/2002 | DE10050490A1 New butenolide or pentenolide amide derivatives, useful as kinase inhibitors for treating inflammatory and autoimmune diseases, e.g. rheumatoid arthritis, asthma, Alzheimer's disease or osteoarthritis |
| 04/25/2002 | CA2423933A1 Pharmaceutically active sulfanilide derivatives |
| 04/25/2002 | CA2422655A1 Blends of quinone alkide and nitroxyl compounds as polymerization inhibitors |
| 04/24/2002 | EP1198454A1 Mutilin derivatives and their use as antibacterials |
| 04/24/2002 | EP1180366A9 Neuronal death inhibitors |
| 04/24/2002 | CN1346354A Substituted benzoylpyrazoles as herbicides |
| 04/24/2002 | CN1346348A Amide compounds and medicinal use thereof |
| 04/24/2002 | CN1346347A Cyclic amine derivatives and uses thereof |
| 04/24/2002 | CN1345721A Process for preparing photoactivated (-) yellow skin amide |
| 04/24/2002 | CN1083450C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides |
| 04/24/2002 | CN1083443C 吲哚衍生物 Indole derivatives |
| 04/24/2002 | CN1083431C Novel heterocyclic compounds |
| 04/23/2002 | US6376681 Synthesis of compounds useful in the manufacture of ketorolac |
| 04/23/2002 | US6376665 Antiarthritic agents, antiinflammatory agents |
| 04/23/2002 | US6376517 For treating vision loss, preventing vision degeneration, and promoting vision regeneration (?neopsis?) |
| 04/23/2002 | US6376514 Piperidine-derived compounds containing a quinolyl group that inhibits p-glycoprotein transport protein activity; for treating cancer and other diseases |
| 04/23/2002 | US6376507 NK-1 receptor antagonists for the treatment of neuronal injury and stroke |
| 04/23/2002 | US6376489 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/23/2002 | US6376476 Isoprenoid pathway inhibitors for stimulating bone growth |
| 04/23/2002 | US6376452 Cleaning process and composition using fluorocarbons |
| 04/23/2002 | US6376230 Stereoselective process for producing intermediates of cryptophycins |
| 04/23/2002 | US6376142 Electrophotosensitive material containing specific maleimide derivative |
| 04/23/2002 | CA2223403C Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) n-¬(aminoiminomethyl)phenylalkyl|-azaheterocyclylamide compounds |
| 04/18/2002 | WO2002031025A2 Biodegradable poly(beta-amino esters) and uses thereof |
| 04/18/2002 | WO2002030929A1 Novel pleuromutilin derivatives |
| 04/18/2002 | WO2002030894A2 Compositions and methods of the use thereof achiral analogues of cc-1065 and the duocarmycins |
| 04/18/2002 | WO2002030893A1 Processes for producing compound for antibacterial compound production therefrom and intermediate therefor |
| 04/18/2002 | WO2002030892A1 Butenolide and pentenolide derivatives as kinase inhibitors |
| 04/18/2002 | WO2002030890A1 Nitrogenous five-membered ring compounds |
| 04/18/2002 | WO2002012210A9 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 04/18/2002 | WO2002012166A3 Triamine derivative melanocortin receptor ligands and methods of using same |
| 04/18/2002 | WO2002003995A3 Treatment of male sexual dysfunction |
| 04/18/2002 | WO2001087830A3 Substituted thioacetamides |
| 04/18/2002 | WO2001026644A3 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 04/18/2002 | US20020045777 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes. |
| 04/18/2002 | US20020045763 Process for the preparation of 3-amino-2-oxo-pyrrolidines, novel intermediates and their use |
| 04/18/2002 | US20020045749 Antibacterial agents |
| 04/18/2002 | US20020045654 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
| 04/18/2002 | US20020045641 Multiple heteroatom containing heterocyclic ring compounds substituted with carboxylic acids and isosteres thereof |
| 04/18/2002 | US20020045629 Sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators |
| 04/18/2002 | US20020045231 Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies |
| 04/18/2002 | DE10122447A1 Biphenylcarboxamide Biphenylcarboxamides |
| 04/18/2002 | DE10047116A1 DELTA·1·-Pyrroline DELTA · 1 · -Pyrrolines |
| 04/18/2002 | DE10047110A1 Optisch aktive 2,5-Bisaryl-DELTA·1·-Pyrroline Optically active 2,5-bis-aryl DELTA · 1 · -Pyrrolines |
| 04/17/2002 | EP1196411A1 Bradykinin b1 receptor antagonists |
| 04/17/2002 | EP1196404A1 Piperazine derivatives as modulators of chemokine receptor activity |
| 04/17/2002 | EP1196400A1 Amino-alkyl derivatives |
| 04/17/2002 | EP1196389A1 N-heterocyclic derivatives with neuronal activity |
| 04/17/2002 | EP1196379A2 INHIBITORS OF FACTOR Xa |
| 04/17/2002 | EP1196371A1 Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity |
| 04/17/2002 | EP0831911B1 Spironolactone and angiotensin ii antagonist combination therapy for treatment of congestive heart failure |
| 04/17/2002 | EP0807632B1 Pyrroloazepine derivatives |
| 04/17/2002 | CN1345311A 1-arenesulfonyl-2-aryl-pyrolidine and piperidine derivatives for treatment of CNS disorders |
| 04/17/2002 | CN1345310A Method of N-acyl-producing 3,4-dihydroprolines and N-acyl-3,4-dehydropiperidines-2-carboxylic derivatives |
| 04/17/2002 | CN1345308A Acetylenic alpha-amino acid based sulfonamide hydroxamic acid TACE inhibitors |
| 04/17/2002 | CN1345239A Heterocyclic containing biphenyl alpha P2 inhibitors and method |
| 04/17/2002 | CN1082815C 吲哚衍生物 Indole derivatives |
| 04/17/2002 | CN1082790C Herbicides |
| 04/16/2002 | US6372943 Polyenepolycarboxylic acids, derivatives thereof with respect to carboxyl groups, or salts of these |
| 04/16/2002 | US6372914 Intermediates useful for the manufacture of carbapenem and a stereoselective manufacturing method therefor |
| 04/16/2002 | US6372778 Sulfonamide inhibitors of aspartyl protease |
| 04/16/2002 | US6372777 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/16/2002 | US6372758 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 04/16/2002 | CA2087414C Arylcycloalkyl derivatives their production and their use |
| 04/11/2002 | WO2002028881A1 Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration |
| 04/11/2002 | WO2002028830A1 Novel phenylalanine derivatives |
| 04/11/2002 | WO2002028829A2 Peptide deformylase inhibitors |
| 04/11/2002 | WO2002028820A1 Nitroso diphenylamine derivatives |
| 04/11/2002 | WO2002028815A1 Pharmaceutical compounds |
| 04/11/2002 | WO2002028813A1 Low shrinkage thermosetting resin compositions and methods of use therefor |
| 04/11/2002 | WO2002028810A2 Retinoids for the treatment of emphysema |
| 04/11/2002 | WO2002028389A1 Antitumor therapy comprising distamycin derivatives |
| 04/11/2002 | US20020042536 Preparation of amino-protected lysine derivatives |
| 04/11/2002 | US20020042524 Process for cis-1{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy] ethyl}pyrrolidine |
| 04/11/2002 | US20020042523 Reacting an amino-protected aspartic anhydride with an aralkylamine, cyclodehydration to obtain a 1-aralkyl-3-(protected amino)pyrrolidine-2,5-dione, reducing carbonyl groups, then hydrogenolysis; carbapenems, drug intermediate |
| 04/11/2002 | US20020042522 Process for the preparation of derivative of 4-amino-3-hydroxypyrrole-2-carboxylic acid |
| 04/11/2002 | US20020042517 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 04/11/2002 | US20020042508 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same |
| 04/11/2002 | US20020042443 Estrogen agonist / antagonist metabolites |
| 04/11/2002 | US20020042442 Ureas and carbamates of N-Heterocyclic carboxylic acids and carboxylic acid isosteres |
| 04/11/2002 | US20020042431 Zwitterionic tachykinin receptor antagonists |
| 04/11/2002 | US20020042408 Antibiotic compounds |
| 04/11/2002 | US20020042406 Ring opening metathesis of alkenes |
| 04/11/2002 | US20020042399 Analgesics; skin disorders |
| 04/11/2002 | US20020042398 Novel lactam metalloprotease inhibitors |
| 04/11/2002 | US20020042396 Amino acid derivatives |